December 19, 2024 5:10 PM

First malaria vaccine shows promise amid rising cases: report

The first blood-stage malaria vaccine, RH5.1/Matrix-M, has shown promise as a potential component in an evolving malaria vaccine strategy, according to a report released on Thursday. The report by GlobalData, a data and analytics company, revealed that 11 other malaria vaccines are currently in Phase II development. A recent study conducted by researchers in Burkina Faso and the UK found that RH5.1/Matrix-M is safe, effective, and highly immunogenic. The double-blind, randomized, controlled P...